Skip to main content

Cellular Dynamics, Roche Update Alliance Covering Cardiotoxicity Platform

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that its agreement with Roche to substantiate CDI's platform for assessing the potential toxicity of drug candidates for heart disease has progressed to a standard supply agreement.

The two-year agreement, which took effect in March 2009, to substantiate CDI's iCell Cardiomyocytes as a predictive tool was completed early, and the platform will now be incorporated into Roche's drug development decision-making process, CDI said.

The agreement originally was to evaluate the iCell Cardiomyocytes tool against a well-characterized compound reference set in order to test the myocytes' ability to predict drug-induced, potentially life-threatening cardiac arrhythmias. Testing involved longitudinal genetic and molecular characterizations of the cardiomyocytes and comparing their performance across established and new testing platforms designed to detect possible cardiotoxic effects of new compounds early in their development cycle.

"We have developed iCell Cardiomyocytes as a cardiac cell model that truly reflects human biology," Robert Palay, chairman and CEO of CDI, said in a statement. "In addition, we have developed a manufacturing process that enables us to reliably deliver the cells in the quantity, quality, and purity that our customers require to successfully accomplish their drug discovery and toxicity testing research."

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.